本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Pacira Pharmaceuticals

24.29
+0.21000.87%
成交量:1.07萬
成交額:25.83萬
市值:9.68億
市盈率:69.05
高:24.32
開:24.06
低:24.06
收:24.08
52周最高:27.66
52周最低:18.80
股本:3,986.19萬
流通股本:3,636.93萬
量比:0.32
換手率:0.03%
股息:- -
股息率:- -
每股收益(TTM):0.3518
每股收益(LYR):0.1578
淨資產收益率:2.05%
總資產收益率:1.48%
市淨率:1.44
市盈率(LYR):153.90

資料載入中...

2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/05/11

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/05/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/03

重要事件披露

8-K - Current report
2023/04/03

關聯方擬減持公告

144 - Report of proposed sale of securities
2023/04/03

重要事件披露

8-K - Current report
2023/03/22

重要事件披露

8-K - Current report
2023/02/28

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/02/28

重要事件披露

8-K - Current report
2023/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals